Clinical Trials
4 trialsNCT04053114 2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn
NCT02211027 2017-09-07
Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA
University of Pittsburgh
Phase 1 Withdrawn
NCT00377247 2016-07-11
Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
University of Pittsburgh
Phase 1 Terminated
NCT00898742 2013-04-02
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Terminated